These recalls involve products that pose serious risks of injury or death. Check if you own any of these products and take immediate action if needed.
783 critical product recalls that require immediate attention. These products have been identified as posing serious safety hazards.
Inpeco S.A. recalled one unit of the FlexLab X (FXX) System on September 3, 2025. The recall affects the Sample Integrity Module, which has not been FDA evaluated for safety. This may cause erroneous results or delays in patient testing.
Failed Impurities/Degradation Specifications
New Spirit Naturals recalled 37 units of Ultra Whey Protein Powder on September 3, 2025. The recall is due to undeclared milk allergen ingredients. Consumers should stop using the product immediately.
Philips Medical Systems recalled 313 cardiac monitors on September 3, 2025, due to a BIOS battery issue. The battery may deplete unexpectedly, halting the device's start-up process without warning. Patients and healthcare providers must stop using the device immediately.
Inpeco S.A. recalled eight units of its FlexLab (FLX) Potassium Test System on September 3, 2025. The system's Sample Integrity Module may produce erroneous results due to unverified functions. Healthcare providers must stop using the device immediately and follow the manufacturer's instructions.
Beckman Coulter recalled 2,146 units of SYNCHRON Systems Phosphorus reagents on September 3, 2025. The affected lots may fail calibration before expiration, delaying patient results. Healthcare providers must stop using the product immediately.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD10 Operating Room Table on September 3, 2025. The BIOS battery may deplete faster than expected, halting the system's start-up process. This recall affects two units distributed worldwide, including the U.S. and multiple countries.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD20 Biplane OR Table on September 3, 2025, due to a potential BIOS battery failure. The recall affects four units distributed globally, including two in the U.S. and two internationally.
Philips Medical Systems Nederland B.V. recalled 300 Allura Xper FD20/15 devices on September 3, 2025. The BIOS battery may deplete too quickly, halting system start-up. Users may not receive any warning before the battery fails.
Philips Medical Systems recalled 501 Allura Xper FD20 Biplane systems on September 3, 2025. The BIOS battery may deplete quickly, halting system startup without warning. The recall affects devices distributed worldwide, including the US and several countries in Europe and Asia.
Philips Medical Systems Nederland B.V. recalled 87 Allura Xper FD20/10 medical imaging devices on September 3, 2025. The BIOS battery may deplete faster than expected, halting the system's start-up process without warning. Healthcare providers and patients should stop using these devices immediately.
Philips Medical Systems Nederland B.V. recalled 5,067 Allura Xper FD20 devices on September 3, 2025. The BIOS battery may deplete unexpectedly, halting the system's start-up process. This issue affects models 722006, 722012, and 722028 and poses a high risk to patient safety.
Philips Medical Systems recalled 2,317 Allura Xper FD10 systems on September 3, 2025. The BIOS battery may deplete faster than expected, halting the system startup. Affected models include 722003, 722010, and 722026.
Philips Medical Systems Nederland B.V. recalled 53 Allura Xper CV20 medical imaging systems on September 3, 2025. The BIOS battery may deplete faster than anticipated, halting the system's start-up process. Users will not receive warnings before the battery depletes.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD20/20 operating room table on September 3, 2025, due to a potential BIOS battery failure. The battery may deplete faster than expected, causing the system to halt without warning. This recall affects five units distributed worldwide.
Cardinal Health recalled Sulfamethoxazole and Trimethoprim tablets on September 2, 2025, due to contamination risks. A specific lot contained a foreign substance with a detected micro-organism, although no contamination was found on the tablets. Consumers must stop using the product immediately and seek guidance from healthcare providers.
Major Pharmaceuticals recalled Sulfamethoxazole and Trimethoprim tablets on September 2, 2025, due to contamination concerns. A foreign substance was found in the packaging material, although the tablets themselves remain unaffected. Consumers should stop using the product immediately and consult healthcare providers.
AvKARE recalled 2,192 cartons of Norgestimate and Ethinyl Estradiol Tablets on September 2, 2025. The tablets failed content uniformity specifications, posing a high hazard risk. Consumers should stop using the product immediately and consult their healthcare provider.
Canon Medical System recalled eight digital radiography systems on September 2, 2025. The software issue may leave X-ray areas partially covered by static images. Users should stop using the device immediately and follow recall instructions.
LeMaitre Vascular recalled 28 units of Artegraft Collagen Vascular Grafts on September 2, 2025. The recall affects multiple model numbers due to unapproved sourcing of raw materials. Patients and healthcare providers must stop using the device immediately and follow recall instructions.